secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001193125-23-052192
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus settles CartiHeal option for $10M, eliminates up to $350M in contingent payments
--------------------------------------------------------------------------------

- Bioventus LLC paid $10M non-refundable to CartiHeal securityholders and $150k to expense fund.
- Mutual release of claims; escrowed CartiHeal shares returned to trustee for securityholders.
- Eliminated obligations of $215M in Post-Closing Tranches plus interest, or up to $350M if Sales Milestone triggered.
- Bioventus retains option to pay full $215M+ within 30-60 days to reinstate acquisition and Sales Milestone.
- CartiHeal to operate in ordinary course during Interim Period with $2M cash minimum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000119312523052192/0001193125-23-052192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000119312523052192/d439963d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-052192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer